tiprankstipranks
MGC Pharmaceuticals (AU:MXC)
ASX:MXC

MGC Pharmaceuticals (MXC) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
9Bearish
MGC Pharmaceuticals’s (MXC) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting MGC Pharmaceuticals is a Buy.
MGC Pharmaceuticals’s (MXC) 20-Day exponential moving average is 0.42, while MGC Pharmaceuticals’s (MXC) share price is AU$0.41, making it a Sell.
MGC Pharmaceuticals’s (MXC) 50-Day exponential moving average is 0.57, while MGC Pharmaceuticals’s (MXC) share price is AU$0.41, making it a Sell.

MGC Pharmaceuticals (MXC) Pivot Points

May 07, 2024, 10:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.38
0.39
0.40
0.41
0.43
0.44
0.45
Fibonacci
0.39
0.40
0.40
0.41
0.42
0.43
0.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MGC Pharmaceuticals (MXC) Moving Averages

May 07, 2024, 10:24 PM
Period
Simple
Exponential
MA5
0.41Sell
0.41Sell
MA10
0.42Sell
0.42Sell
MA20
0.43Sell
0.42Sell
MA50
0.41Buy
0.57Sell
MA100
0.50Sell
1.16Sell
MGC Pharmaceuticals’s (MXC) 10-Day exponential moving average is 0.42, while MGC Pharmaceuticals’s (MXC) share price is AU$0.41, making it a Sell.
MGC Pharmaceuticals’s (MXC) 100-Day exponential moving average is 1.16, while MGC Pharmaceuticals’s (MXC) share price is AU$0.41, making it a Sell.
MGC Pharmaceuticals’s (MXC) stock price is AU$0.41 and MGC Pharmaceuticals’s (MXC) 50-day simple moving average is 0.41, creating a Buy signal.
MGC Pharmaceuticals’s (MXC) stock price is AU$0.41 and MGC Pharmaceuticals’s (MXC) 100-day simple moving average is 0.50, creating a Sell signal.

MGC Pharmaceuticals (MXC) Technical Indicators

May 07, 2024, 10:24 PM
Name
Value
Implied Action
RSI (14)
46.37
Neutral
STOCH (9,6)
38.15
Neutral
STOCHRSI (14)
36.36
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
13.89
Buy
Williams %R
-60.00
Buy
CCI (14)
-98.33
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
61.73
Neutral
ROC
-3.53
Sell
MGC Pharmaceuticals’s (MXC) Relative Strength Index (RSI) is 46.37, creating a Neutral signal.
MGC Pharmaceuticals’s (MXC) Trend Strength Indicator (ADX) is 13.89, creating a Buy signal.
MGC Pharmaceuticals’s (MXC) Commodity Channel Index (CCI) is -98.33, creating a Neutral signal.
MGC Pharmaceuticals’s (MXC) Price Rate of Change (ROC) is -3.53, creating a Sell signal.

FAQ

Is MXC a Buy, Hold, or Sell?
Based on MXC’s technical indicators, MXC is a Sell.
    What is MXC’s RSI (14)?
    MXC’s RSI (14) is 46.37, which suggests MXC is a Neutral.
      What is MXC’s MACD?
      MXC’s MACD is >-0.01, which suggests MXC is a Buy.
        What is MXC’s 5-day moving average?
        MXC’s 5-day moving average is 0.41, which suggests MXC is a Sell.
          What is MXC’s 20-day moving average?
          MXC 20-day moving average is 0.43, which suggests MXC is a Sell.
            What is MXC’s 50-day moving average?
            MXC’s 50-day moving average is 0.41, which suggests MXC is a Buy.
              What is MXC’s 200-day moving average?
              Currently, no data Available
              What is MXC’s Williams % R (14)?
              MXC’s Williams % R (14) is -60.00, which suggests MXC is a Buy.
                What is MXC’s CCI (14)?
                MXC’s CCI (14) is -98.33, which suggests MXC is a Neutral.
                  What is the share price of MGC Pharmaceuticals?
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis